Study participants
esophageal cancer, D) Muscle mass
OESOPHAGEAL CANCER
Patient enrolment was consecutive and lasted from January 2016 to August 2020. A total of 243 survivors from the OSCAR study were assessed for eligibility. Of them, 233 met the inclusion criteria, but 72 declined to participate. The remaining 161 participants (69.1% of those eligible) were randomly assigned to either the intervention group (Patient characteristics are presented in Table The compliance rate in the intervention group was 91%. The changes in the means between baseline and post‐intervention, comparing the intervention with control group for all the primary outcome measures are presented as a panel graph in Figure Panel graph showing changes in means of the primary outcomes. (A) Maximal hand grip strength; (B) Average hand grip strength; (C) Lower extremity strength; (D) Muscle mass assessed between 1 year after surgery for esophageal cancer (baseline) and after approximately 12 weeks of physical activity‐based intervention (follow‐up)